Read articles from Global

November 17, 2025 by regulatorwatch.com

It's excellent, thank you. I'm sharing this on NSP

Live from Geneva, Switzerland – RegWatch brings you exclusive coverage of the Taxpayers Protection Alliance’s Good COP 2.0, a tobacco harm reduction counter-conference held alongside the WHO’s COP 11. Good COP 2.0 gathers 37 experts from 22 countries to distinguish facts from myths and challenge the misinformation influencing global health policy.

November 14, 2025 by substack.com

WHO position on harm reduction : enough is enough

The WHO recently released a paper on tobacco control and harm reduction before the FCTC COP-11. It discusses harm reduction in tobacco and nicotine products, refuting claims that non-combustible products are as harmful as cigarettes and criticizing the WHO's stance on harm reduction as aligned with the tobacco industry. The document calls for prohibition and restrictive measures against these products, ignoring their potential role in reducing harm from smoking. These recommendations may inadvertently protect the cigarette market, contradicting the WHO's objectives. It emphasizes the need for a balanced approach to tobacco control.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by filtermag.org

Grassroots Harm Reduction Sidelined in NY Opioid Fund Spending

Alexis Pleus shared how her son's opioid addiction journey began with a knee injury and prescribed medication, leading to addiction and tragic consequences. She founded Truth Pharm for harm reduction advocacy after losing her sons to overdose. Despite effective community outreach, small organizations like hers lack funding, with major portions going to large hospitals. New York's $3 billion Opioid Settlement Fund mostly supports big institutions, sidelining local groups. The Drug Policy Alliance calls for equitable distribution to combat overdose fatalities, highlighting discriminations faced by those with substance use disorders. Pleus emphasizes the vital role of grassroots groups in filling gaps left by larger systems.

November 14, 2025 by filtermag.org

Grassroots Harm Reduction Sidelined in NY Opioid Fund Spending

Alexis Pleus shared how her son's opioid addiction journey began with a knee injury and prescribed medication, leading to addiction and tragic consequences. She founded Truth Pharm for harm reduction advocacy after losing her sons to overdose. Despite effective community outreach, small organizations like hers lack funding, with major portions going to large hospitals. New York's $3 billion Opioid Settlement Fund mostly supports big institutions, sidelining local groups. The Drug Policy Alliance calls for equitable distribution to combat overdose fatalities, highlighting discriminations faced by those with substance use disorders. Pleus emphasizes the vital role of grassroots groups in filling gaps left by larger systems.

November 13, 2025 by vejpkollen.se

International researchers: “WHO risks lives by discouraging smoke-free alternatives”

Leading scientists criticize the WHO for discouraging smoke-free alternatives like e-cigarettes, snus, and nicotine pouches that can reduce nicotine risks. The organization views harm reduction as a tobacco industry scheme, sparking debate among experts who argue for a more science-based approach. Researchers urge the WHO to engage in open dialogue on smoke-free nicotine products to advance public health goals. Critics note the success of these alternatives in helping smokers quit and reducing harm. The debate highlights the need for evidence-based regulation and a shift towards inclusive discussions to promote a smoke-free society globally.

November 13, 2025 by medicalxpress.com

Opinion: How e-cigarettes compromise children's human rights

Experts argue that exposing children to e-cigarettes violates their rights, urging regulations prioritizing children's well-being. With youth e-cigarette use outpacing adults' globally, the World Health Organization stresses that children are more vulnerable to nicotine's harms due to ongoing brain development. Despite legal obligations to protect children under the UN Convention, 62 countries lack e-cigarette regulations. Advocates emphasize the need for stringent regulations to curb youth usage, including sales bans and marketing restrictions. Governments must address enforcement challenges like online marketing to effectively safeguard children's health. Neglecting children's well-being in e-cigarette regulation may have enduring negative repercussions.

November 13, 2025 by sciencedaily.com

New study finds hidden diabetes danger in vaping

Research from the University of Georgia shows that using e-cigarettes, traditional cigarettes, or both increases the risk of developing diabetes. Lead author Sulakshan Neupane highlights the potential health risks associated with e-cigarette use, with vaping alone linked to a 7% increase in prediabetes risk. The study also found that smoking cigarettes or cigars raised prediabetes risk by 15%, with even higher risks for dual users. Factors such as weight, income, and demographics further influenced the likelihood of developing these conditions. Neupane suggests that regular physical activity may help counter some harmful effects. The study emphasizes the need for public health efforts to address smoking and diabetes outcomes.